Introduction Sexually transmitted diseases (STDs) remain a serious global public‑health challenge — and diagnostics are critical for early detection, treatment and control. The diagnostics segment for STDs is undergoing transformative change: new technologies, regulatory shifts, self‑testing, telehealth linkages and rising demand in emerging markets. Understanding this market is vital...